The Impact of Individual Co-Morbidities in Myeloablative Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation
2020 ◽
Vol 26
(3)
◽
pp. S141
2017 ◽
Vol 23
(11)
◽
pp. 2004-2011
◽
2018 ◽
Vol 24
(1)
◽
pp. 133-141
◽
2006 ◽
Vol 12
(2)
◽
pp. 5
2014 ◽
Vol 20
(2)
◽
pp. S277-S278
2010 ◽
Vol 46
(10)
◽
pp. 1296-1302
◽
2018 ◽
Vol 24
(3)
◽
pp. S427-S428
2017 ◽
Vol 23
(3)
◽
pp. S286-S287
2018 ◽
Vol 24
(3)
◽
pp. S83-S84